Keratoconjunctivitis Sicca = Dry Eye Disease

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/10

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

11 Terms

1
New cards

Dry Eye Disease Overview

keratoconjunctivitis sicca, dry eye syndrome, and dysfunction tear syndrome.

Keratoconjunctivitis sicca is dryness of the conjunctiva and cornea.

2
New cards

Dry Eye Disease and Ocular Surface Disease (OSD)

ocular surface disease which indicates damage to the surface layers of the eye, namely the cornea and conjunctiva.

The most common causes of OSD are:

  • Dry eye

  • Blepharitis (inflammation of the eyelids)

  • Meibomianitis

Severe OSD may precipitate secondary keratitis and conjunctivitis, corneal ulceration and scarring, and permanent vision loss.

3
New cards

TFOS DEWS II Definition: Dry Eye

tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities

is evaporation induced tear hyperosmolarity resulting in ocular surface damage and inflammation.

Key etiologies include tear hyperosmolarity, tear film instability, ocular surface inflammation and damage, and neurosensory abnormalities.

All forms of dry eye disease have an evaporative component.

4
New cards

Classification of Dry Eye Disease (DED)

Two Forms of Dry Eye (non-mutually exclusive = continuum)

  1. Aqueous Deficient Dry Eye (ADDE): reduced tear secretion

  • decreased tear volume disorder of lacrimal gland function

  • Sjögren syndrome dry eye (NSDE)

    • A chronic autoimmune disease characterized by immune cell infiltration of exocrine glands

  1. Evaporative Dry Eye (EDE): excessive tear evaporation

  • Meibomian gland dysfunction or increased palpebral fissure width (the opening between the eyelids) leads to increased evaporation or an anomaly of tear distribution.

  • Normal lacrimal function

5
New cards

Risk Factors for Dry Eye Disease

1st generation antihistamines (anti-cholinergic)

Oral contraceptives (hormone therapy)

<p>1st generation antihistamines (anti-cholinergic)</p><p>Oral contraceptives (hormone therapy)</p>
6
New cards

Tear Supplementation: Artificial Tears - General Components

• Preservatives: Prevent the growth of microorganisms.

Viscosity-Increasing Agents: Prolong contact time by slowing drainage from the eye.

Demulcents: Water soluble polymers that are used to protect and lubricate the ocular surface.

Emollients: Fat-based or oil-based products that seek to replicate the lipid layer of the eye.

Antioxidants: Prevent or delay deterioration by oxygen.

• Wetting Agents: Reduce surface tension, allowing the drug solution to spread across ocular surface.

• Buffers: Maintain ophthalmic products in the pH range of 6 to 8.

• Tonicity Agents: Maintain isotonicity with preocular tear film (0.6%-1.8%).

7
New cards

Tear Supplementation: Artificial Tears -- Preservatives

Three main categories of preservatives in ophthalmic preparations

– Chemical

– Oxidizing agents (less toxic than chemical)

– Ionic buffered (less toxic than chemical)

<p>Three main categories of preservatives in ophthalmic preparations</p><p>– Chemical</p><p>– Oxidizing agents (less toxic than chemical)</p><p>– Ionic buffered (less toxic than chemical)</p>
8
New cards

Tear Supplementation: Artificial Tears -- Chemical Preservatives

Detergents:

  • Benzalkonium Chloride (BAK, BZAK) , Benzethonium chloride, Polyquaternium-1 (Polyquad).

    • MOA: Disruption of bacterial cell membranes (bactericidal).

    • Benzalkonium Chloride toxic to corneal epithelium and tear film.

    • Polyquaternium-1 (Polyquad®) is less toxic

Mercurial derivatives: thimerosal,

  • MOA: Inhibits microbial metabolism.

  • Thimerosal is responsible for contact sensitivity

Biguanides or Amides: : polyhexamethylene biguanide (PHMB), chlorhexidine, polyaminopropyl biguanide (PAPB).

  • MOA: Disruption of bacterial cell membranes (bactericidal).

  • Known for activity against Acanthamoeba

  • Used in multipurpose contact lens solutions.

Alcohols: chlorobutanol (detergent), benzyl alcohol, phenylethenol

  • MOA: Disruption of bacterial cell membranes (bactericidal).

  • Benzyl alcohol is responsible for hypersensitivity reactions.

Miscellaneous:

  • Sorbic Acid

    • MOA: Is an antioxidant.

    • An organic acid

  • Methylparaben and Propylparaben (Parabens esters as a class)

    • MOA: Inhibits microbial metabolism.

    • Responsible for contact dermatitis (sensitivity) allergic reactions

  • Disodium EDTA (ethylenediaminetetraacetic acid)

    • MOA: Has antioxidant properties and is also chelating agent that binds divalent cations (unique action) which disrupts cell membranes.

    • Responsible for contact dermatitis.

  • Sodium bisulfite and metabisulfite (“sulfites”)

    • MOA: Is an antioxidant

9
New cards

Tear Supplementation: Artificial Tears -- Oxidizing Preservatives

Stabilized Oxychloro-Complex (Purite®) and Sodium Perborate (GenAqua®)

  • MOA: Oxidative preservative systems.

10
New cards

Tear Supplementation: Artificial Tears -- Ionic Buffered Preservatives

SofZia®

  • MOA: Ionic buffered preservative system.

  • When exposed to cations in the tear film of the eye, SofZia® breaks up into innate ingredients.

    • The SofZia® preservative system is used in Travatan Z® (travoprost).

11
New cards

Tear Supplementation: Artificial Tears -- Viscosity-Increasing Agents

Viscosity-Increasing Agents: Prolong contact time by slowing drainage from the eye.

Polymers are used in artificial tear solutions or tear substitute solutions as viscosity increasing agents.

  • The most common viscoelastic or pseudoplastic polymers are:

    • Polysaccharides/Cellulose Ethers

    • Vinyl derivatives (water soluble polymers)

Viscoelastic agents exhibit both viscous and elastic characteristics when undergoing deformation (e.g., stretchability, adaptability, ability to change). Viscosity decreases with increasing shear rate (blinking) for greater patient acceptance.